The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis - Université de Bretagne Occidentale Accéder directement au contenu
Article Dans Une Revue Journal of Autoimmunity Année : 2019

The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis

Résumé

To investigate serum IL-6 (sIL-6) levels during active disease, complete remission (CR), and relapse in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), and to explore the association of changes in sIL-6 with clinical outcomes.

Dates et versions

hal-02190392 , version 1 (22-07-2019)

Identifiants

Citer

Alvise Berti, Roscoe Warner, Kent Johnson, Divi Cornec, Darrell Schroeder, et al.. The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis. Journal of Autoimmunity, 2019, pp.102302. ⟨10.1016/j.jaut.2019.07.001⟩. ⟨hal-02190392⟩
48 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More